Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20547256 | 0.92 | MEN1 (0.52) | MEN1TP53KMT2ATSHRALDH1A1 | |
| SCHEMBL36422 | 0.92 | MEN1 (0.52) | MEN1TP53KMT2ATSHRALDH1A1 | |
| SCHEMBL12764462 | 0.90 | SMN1; SMN2 (0.52) | MEN1TP53KMT2ATSHRSMN1; SMN2 | |
| Charcoal, Activated SCHEMBL30277426 | 0.90 | MEN1 (0.50) | MEN1TP53KMT2ATSHRALDH1A1 | |
| SCHEMBL28170140 | 0.90 | MEN1 (0.50) | MEN1TP53KMT2ATSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL23497791 | 0.90 | MEN1 (0.50) | MEN1TP53KMT2ATSHRALDH1A1 | |
| SCHEMBL2791593 | 0.90 | SMN1; SMN2 (0.52) | MEN1TP53KMT2ATSHRSMN1; SMN2 | |
| Bromide SCHEMBL31199104 | 0.90 | MEN1 (0.50) | MEN1TP53KMT2ATSHRALDH1A1 | |
| Hydroxyl Radical SCHEMBL28076004 | 0.90 | MEN1 (0.50) | MEN1TP53KMT2ATSHRALDH1A1 | |
| SCHEMBL28120480 | 0.88 | MEN1 (0.48) | MEN1TP53KMT2ATSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3110564-A1 | RADIATION CURABLE INKS AND COATINGS CONTAINING DIACETONE ACRYLAMIDE | Sun Chemical Corporation (US) | 2017-01-04 | — | — | EP | disclosed |
| US-20160340529-A1 | RADIATION CURABLE INKS AND COATINGS CONTAINING DIACETONE ACRYLAMIDE | SUN CHEMICAL CORPORATION (US) | 2016-11-24 | — | — | US | disclosed |
| CN-105732541-A | Bifunctional monomer and preparation method thereof | 无锡海特圣大光电材料科技有限公司 | 2016-07-06 | — | — | CN | disclosed |
| WO-2015131029-A1 | RADIATION CURABLE INKS AND COATINGS CONTAINING DIACETONE ACRYLAMIDE | SUN CHEMICAL CORPORATION (US) | 2015-09-03 | — | — | WO | disclosed |
| US-6825339-B2 | IMMOBILIZATION TO POROUS SOLID SUPPORT; OXIDATION USING IODINE IN GLACIAL ACETIC ACID | PROLIGO, LLC | 2004-11-30 | — | — | US | disclosed |
| US-6623703-B1 | Efficient synthesis of oligonucleotides | PROLIGO, LLC | 2003-09-23 | — | — | US | disclosed |
| US-20030176690-A1 | Apparatus for preparing polynucleotides on a solid support | PROLIGO, LLC | 2003-09-18 | — | — | US | disclosed |
| US-6590092-B1 | Oligonucleotide synthesis wherein nucleotides are incorporated onto a substrate of given formula; can be used irrespective of the first RNA or DNA nucleotide to be synthesized and irrespective of the monomer reagent used cleavage using a | NGO NAM Q (US) | 2003-07-08 | — | — | US | disclosed |
| US-6469157-B1 | USING A COLUMN CONTAINING AN IMMOBILIZED SOLID SUPPORT THAT IS FUNCTIONALIZED FOR POLYNUCLEOTIDE SYNTHESIS | PROLIGO LLC | 2002-10-22 | — | — | US | disclosed |
| US-20020103365-A1 | PROCESS FOR THE SYNTHESIS OF NUCLEIC ACIDS ON A SOLID SUPPORT AND COMPOUNDS WHICH ARE USEFUL IN PARTICULAR AS SOLID SUPPORTS IN THE SAID PROCESS | PROLIGO, LLC | 2002-08-01 | — | — | US | disclosed |
| US-5869643-A | DEPROTECTION, FIRST WASHING, ADDING BASE TO FORM INTERNUCLEOTIDE BONDING, SECOND WASHING, OXIDATION AND THIRD WASHING | GENSET (FR) | 1999-02-09 | — | — | US | disclosed |
| EP-0707592-B1 | PROCESS FOR SOLID SUPPORT NUCLEIC ACID SYNTHESIS AND COMPOUNDS USEFUL AS SOLID SUPPORTS IN SAID PROCESS | GENSET SA (FR) | 1997-09-03 | — | — | EP | disclosed |
| EP-0658566-B1 | Process of polynucleotide preparation on a solid support and apparatus allowing it to be carried out | GENSET SA (FR) | 1997-07-02 | — | — | EP | disclosed |
| EP-0707592-A1 | PROCESS FOR SOLID SUPPORT NUCLEIC ACID SYNTHESIS AND COMPOUNDS USEFUL AS SOLID SUPPORTS IN SAID PROCESS | GENSET SA (FR) | 1996-04-24 | — | — | EP | disclosed |
| EP-0658566-A1 | Process of polynucleotide preparation on a solid support and apparatus allowing it to be carried out | GENSET SA (FR) | 1995-06-21 | — | — | EP | disclosed |
| WO-1995001987-A1 | PROCESS FOR SOLID SUPPORT NUCLEIC ACID SYNTHESIS AND COMPOUNDS USEFUL AS SOLID SUPPORTS IN SAID PROCESS | GENSET (FR) | 1995-01-19 | — | — | WO | disclosed |
| EP-0206913-B1 | SUPPORTS, THE PREPARATION OF THESE SUPPORTS, INTERMEDIATES OBTAINED, THEIR USE IN THE SYNTHESIS OF OLIGONUCLEOTIDES, AND NUCLEOSIDES AND OLIGONUCLEOTIDES LINKED TO THE SUPPORTS | ROUSSEL-UCLAF (FR) | 1989-09-13 | — | — | EP | disclosed |
| EP-0208599-B1 | SUPPORTS, THEIR PREPARATION AND INTERMEDIATES OBTAINED, THEIR USE IN THE SYNTHESIS OF OLIGONUCLEOSIDES AND THE NUCLEOSIDES SO OBTAINED, AND OLIGONUCLEOTIDES LINKED TO THE SUPPORTS | ROUSSEL-UCLAF (FR) | 1989-08-30 | — | — | EP | disclosed |
| US-4812512-A | SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDES | ROUSSEL UCLAF (FR) | 1989-03-14 | — | — | US | disclosed |
| US-4780504-A | POLYLACTAMS LINKED TO SILICA MICROPELLETS | ROUSSEL UCLAF (FR) | 1988-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020103365-A1 | PROCESS FOR THE SYNTHESIS OF NUCLEIC ACIDS ON A SOLID SUPPORT AND COMPOUNDS WHICH ARE USEFUL IN PARTICULAR AS SOLID SUPPORTS IN THE SAID PROCESS | POLR2H, POLR2E, POLRMT | MEN1 3635/4885TP53 1341/4885KMT2A 394/4885 |
| US-20030176690-A1 | Apparatus for preparing polynucleotides on a solid support | POLN, POLRMT, POLM | MEN1 4116/4885TP53 2884/4885KMT2A 1933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.